Product NDC: | 51079-459 |
Proprietary Name: | Meloxicam |
Non Proprietary Name: | meloxicam |
Active Ingredient(s): | 15 mg/1 & nbsp; meloxicam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-459 |
Labeler Name: | UDL Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077923 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110107 |
Package NDC: | 51079-459-20 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-459-20) > 1 TABLET in 1 BLISTER PACK (51079-459-01) |
NDC Code | 51079-459-20 |
Proprietary Name | Meloxicam |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-459-20) > 1 TABLET in 1 BLISTER PACK (51079-459-01) |
Product NDC | 51079-459 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | meloxicam |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110107 |
Marketing Category Name | ANDA |
Labeler Name | UDL Laboratories, Inc. |
Substance Name | MELOXICAM |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |